⌘K

Login Start Free

Home/Filings/4/0000905718-18-000014

4//SEC Filing

Bell John K 4

Accession 0000905718-18-000014

CIK 0001498382other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:58 PM ET

Size

4.8 KB

Accession

0000905718-18-000014

Insider Transaction Report

Form 4

Period: 2017-12-31

DelMar Pharmaceuticals, Inc.DMPI

Director

Transactions

Other
Common Stock
2017-12-31$3.20/sh+282$902→ 95,301 total(indirect: by Onbelay Capital Inc.)

Footnotes (1)

[F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock

Documents

1 file

4
bell_form4dec312017.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeother

Related Parties

1

filerCIK 0001569585

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 4:58 PM ET
Size: 4.8 KB

View on SEC.gov